N. Yeyin Et Al. , "177Lu-[DOTA0, Tyr3] octreotate therapy in iodine refractory thyroid cancer: Comparison of dosimetry with therapy of thyroid cancer and neuroendocrine tumors," JOURNAL OF NUCLEAR MEDICINE , vol.53, 2012
Yeyin, N. Et Al. 2012. 177Lu-[DOTA0, Tyr3] octreotate therapy in iodine refractory thyroid cancer: Comparison of dosimetry with therapy of thyroid cancer and neuroendocrine tumors. JOURNAL OF NUCLEAR MEDICINE , vol.53 .
Yeyin, N., Toklu, T., Demirci, E., Kabasakal, L., Aygun, A., Ocak, M., ... Selcuk, N.(2012). 177Lu-[DOTA0, Tyr3] octreotate therapy in iodine refractory thyroid cancer: Comparison of dosimetry with therapy of thyroid cancer and neuroendocrine tumors. JOURNAL OF NUCLEAR MEDICINE , vol.53.
Yeyin, Nami Et Al. "177Lu-[DOTA0, Tyr3] octreotate therapy in iodine refractory thyroid cancer: Comparison of dosimetry with therapy of thyroid cancer and neuroendocrine tumors," JOURNAL OF NUCLEAR MEDICINE , vol.53, 2012
Yeyin, Nami Et Al. "177Lu-[DOTA0, Tyr3] octreotate therapy in iodine refractory thyroid cancer: Comparison of dosimetry with therapy of thyroid cancer and neuroendocrine tumors." JOURNAL OF NUCLEAR MEDICINE , vol.53, 2012
Yeyin, N. Et Al. (2012) . "177Lu-[DOTA0, Tyr3] octreotate therapy in iodine refractory thyroid cancer: Comparison of dosimetry with therapy of thyroid cancer and neuroendocrine tumors." JOURNAL OF NUCLEAR MEDICINE , vol.53.
@article{article, author={Nami YEYİN Et Al. }, title={177Lu-[DOTA0, Tyr3] octreotate therapy in iodine refractory thyroid cancer: Comparison of dosimetry with therapy of thyroid cancer and neuroendocrine tumors}, journal={JOURNAL OF NUCLEAR MEDICINE}, year=2012}